Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

NowPatient vs PeptidesRx

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.1

NowPatient

Best for early adopters who want Foundayo via a one-stop telehealth platform

Starting at $199/mo

FoundayoTelehealthBrand Name
Visit NowPatient
7.9

PeptidesRx

Best for patients prioritizing regulatory compliance in the compounded space

Starting at $169/mo

CompoundedSemaglutideTirzepatidePhysician supervised
Visit PeptidesRx

Side-by-Side Comparison

FeatureNowPatientPeptidesRx
Overall Score7.1/107.9/10
Starting Price$199/mo$169/mo
Customer Rating
Features3 features6 features
States Available5150
Compounded✓ Yes
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

NowPatient

Pros

  • Confirmed early Foundayo channel (April 2026 rollout)
  • Daily oral pill — no needles, no refrigeration
  • Telehealth consultation included

Cons

  • Pricing tier not yet publicly verified — confirm directly with the provider
  • State-by-state availability still being phased in
  • Lower mean weight loss vs injectable GLP-1s (~11.1% vs 14.9% Wegovy and 20.9% Zepbound at labeled max)

PeptidesRx

Pros

  • Compliance-focused positioning vs gray-market vendors
  • Board-certified medical director
  • Transparent pricing with no surprise fees
  • Real prescriptions, not research-chemical channel

Cons

  • Smaller scale than Henry Meds or Hims
  • Wide peptide menu may distract from GLP-1 focus

Our Verdict

Winner: PeptidesRxScore: 7.9/10

PeptidesRx edges out NowPatient with a higher overall score of 7.9/10 and is particularly strong for patients prioritizing regulatory compliance in the compounded space. NowPatient remains a solid alternative, especially if you're looking for early adopters who want Foundayo via a one-stop telehealth platform.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.